glp-1 drugs safe New Guidelines for Type 2 Diabetes in 2025 FAQ of the Month: Is

Other considerations include individuals with gastrointestinal issues, as semaglutide may cause nausea, vomiting, or diarrhea, especially during the initial stages of treatment

Have you taken a GLP-1 drug

The consistency across doses suggests this is not simply a downstream effect of weight loss but may represent a direct pharmacological action on inflammatory pathways

this activates the tubulo-glomerular feedback responsible for afferent arteriole dilation and efferent arteriole constriction and, ultimately, leads to glomerular hyperfiltration and hypertension

GLP-1R on arcuate nucleus neurons expressing POMC/CART can mediate Liraglutide-induced weight loss (Secher et al., 2014)

The appeal with GLP-1 is that it cut the pressure and cut the weight